Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 39.38.
Forward PE Ratio (39.38) = Close Price ($353.08) / Consensus Forward EPS ($8.97)
FORWARD PE RATIO
39.38
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+97.74%
vs the sector median at left
West Pharmaceutical Services, Inc.
Market Cap
$24.85B
Forward PE Ratio
39.38
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| West Pharmaceutical Services, Inc. (WST) | $24.85B | 39.38 |
| Incyte Corporation (INCY)vs › | $25.91B | 33.97 |
| STERIS plc (STE)vs › | $23.19B | 23.33 |
| Quest Diagnostics Incorporated (DGX)vs › | $26.97B | 21.84 |
| Labcorp Holdings Inc. (LH)vs › | $27.58B | 18.35 |
| United Therapeutics Corporation (UTHR)vs › | $21.78B | 19.63 |
| Mettler-Toledo International Inc. (MTD)vs › | $28.19B | 29.48 |
| Medline Inc. (MDLN)vs › | $28.97B | 22.71 |
| BioNTech SE (BNTX)vs › | $29.28B | N/A |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $19.54B | 11.84 |
Trailing P/E
45.1
reported TTM EPS
Forward P/E
39.4
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $8.97 implies +14.7% EPS growth vs the reported trailing $7.82.
At today's $353.08 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| Fiscal year end |
|---|
| Consensus EPS |
|---|
| Estimate range |
|---|
| Analysts |
|---|
| Implied P/E |
|---|
| 2026-12-31 | $8.97 | $8.87 – $9.04 | 10 | 39.4x |
| 2027-12-31 | $9.98 | $9.47 – $10.19 | 10 | 35.4x |
| 2028-12-31 | $11.35 | $10.33 – $12.49 | 5 | 31.1x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
